PFG Investments’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,193
Closed -$379K 1046
2024
Q2
$379K Sell
3,193
-252
-7% -$31.9K 0.03% 557
2024
Q1
$367K Buy
+3,445
New +$347K 0.02% 654
2023
Q4
Sell
-2,764
Closed -$285K 518
2023
Q3
$285K Sell
2,764
-1,619
-37% -$181K 0.05% 361
2023
Q2
$533K Buy
4,383
+91
+2% +$12.1K 0.09% 230
2023
Q1
$659K Buy
+4,292
New +$708K 0.13% 175

Other funds holding MRNA

PFG Investments's MRNA Position: Q3 2024 in Review

PFG Investments sold out of Moderna (MRNA) in Q3 2024, closing a stake of 3,193 shares — an estimated $379K sold.

PFG Investments first reported a position in MRNA in Q1 2023 and held it in 5 quarters. The position peaked at $659K in Q1 2023. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • PFG Investments reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • PFG Investments sold 3,193 Moderna shares in Q3 2024, an estimated $379K.
  • PFG Investments first reported a position in Moderna in Q1 2023 and held it in 5 quarters.
  • PFG Investments's Moderna position peaked at $659K in Q1 2023.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on PFG Investments's 13F filing for Q3 2024, filed 24 Oct 2024.